Fierce Pharma
JULY 22, 2024
As lawmakers and industry groups seek to get a handle on U.S. | As lawmakers and industry groups seek to get a handle on U.S. drug shortages, a new white paper from German market analytics firm QYOBO supports the thesis that disproportionately low prices for generic medicines can make it difficult for drugmakers to keep supplies afloat.
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 22, 2024
After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag. | Agilent has revealed that it’s signed a definitive agreement to acquire Biovectra for $925 million through a mix of cash and debt financing. The deal is expected to close this year.
MedCity News
JULY 22, 2024
Anthropic’s Claude3-Opus performed better than GPT-4, but both fell short of humans on a test of objective medical knowledge. The study was conducted by a firm developing LLMs specifically for healthcare that claim to be incorporating peer-reviewed sources of information. The post In This Round, Humans 1, AI LLMs 0 appeared first on MedCity News.
Fierce Pharma
JULY 22, 2024
At his vacation home in Delaware, President Joe Biden made the striking announcement that he is dropping out of the 2024 | While President Joe Biden is officially out for the 2024 election, his term has certainly made a mark in the healthcare realm.
MedCity News
JULY 22, 2024
Ionis Pharmaceuticals is looking ahead to a Phase 3 study for an antisense medicine it is developing to treat Angelman syndrome, a rare neurodevelopmental disorder with no FDA-approved therapies. Its main competition is an Ultragenyx Pharmaceutical drug set to begin pivotal testing later this year. The post Neuro Drug Passed Up by Biogen Posts Positive Data for Ionis, Setting Stage for Phase 3 Test appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JULY 22, 2024
For folks on the transplant waiting list, the wait from now on should be less disruptive. Life should be more pleasant. And all things being equal, one’s condition going into a transplant should be better. The post Home Dialysis Advances Will Make Transplant Wait a Little Easier appeared first on MedCity News.
Fierce Pharma
JULY 22, 2024
The door is closing on bluebird bio’s attempt to secure Medicaid coverage for its fertility support program, which is already offered to patients with commercial insurance who receive its gene ther | The door is closing on bluebird bio’s attempt to secure Medicaid coverage for its fertility support program, which is already offered to patients with commercial insurance who receive its gene therapies.
Spotio
JULY 22, 2024
In both inside and outside sales environments, a lot of emphasis is placed on nurturing leads and closing deals. And while those steps are crucial when it comes to locking down new clients, improving your team’s activity-to-appointment ratio should also be a priority. The first step toward closing a deal is getting a prospect to commit to that first appointment, after all.
MedCity News
JULY 22, 2024
Vitable’s $16 million Series A funding round was led by Cherryrock Capital and included participation from newark venture partners, Citi Impact Fund, First Round Capital, Commerce Ventures and Y Combinator. In total, Vitable has raised more than $25 million. The post Vitable Secures $16M To Provide Primary Care to Small Employers appeared first on MedCity News.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
JULY 22, 2024
As VP Kamala Harris enters the presidential race, her strong stances for reproductive rights and drug access offer insights into future actions.
MedCity News
JULY 22, 2024
Pediatric mental health is the theme of the Pitch Perfect contest at the INVEST Digital Health conference at Pegasus Park in Dallas on September 18. Here’s a look at some of the pediatric mental health companies to watch. The post The Pediatric Innovation Landscape appeared first on MedCity News.
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
MedCity News
JULY 22, 2024
The advancement, adoption of, and access to these options – regardless of age, geography, and financial considerations – requires the support of the scientific community, drug developers, funders, regulatory agencies, insurers, and lawmakers to make the concept of a hormone-free future a reality. The post The Future of Birth Control: No Hormones, More Options for Men appeared first on MedCity News.
pharmaphorum
JULY 22, 2024
Consumer wearables have shown a benefit when used to monitor treatment responses in patients with atrial fibrillation and heart failure.
MedCity News
JULY 22, 2024
Discover the best practices in revenue cycle management to enhance financial health and streamline administrative processes in healthcare. The post Best Practices in Achieving Revenue Cycle Excellence appeared first on MedCity News.
PharmaTimes
JULY 22, 2024
Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK
MedCity News
JULY 22, 2024
In the realm of inclusivity and equity, planning early and engaging key stakeholders throughout the process makes it possible to make these changes while also safeguarding participants. How can researchers put clinical trial equity into practice? The post Implementing Inclusivity: Putting Clinical Trial Equity Into Practice appeared first on MedCity News.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
pharmaphorum
JULY 22, 2024
Scientists at OHSU in the US have developed a universal form of influenza vaccine that they say could protect against all strains of the virus
Pharmaceutical Technology
JULY 22, 2024
The EMA has accepted for review GSK’s MAA for Blenrep for relapsed or refractory multiple myeloma (r/r MM).
pharmaphorum
JULY 22, 2024
Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life-threatening mosquito-borne disease.
PharmaTimes
JULY 22, 2024
Primary sclerosing cholangitis is estimated to affect one in 100,000 people worldwide annually
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
JULY 22, 2024
Pain medicine specialist Grünenthal has agreed to buy Valinor Pharma for $250m, getting control of Movantik for opioid-induced constipation
Pharmaceutical Commerce
JULY 22, 2024
The latest news for pharma industry insiders.
pharmaphorum
JULY 22, 2024
Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and Eli Lilly.Mazdutide – a once-weekly injectable Innovent licensed from Lilly – was submitted to China's National Medical Products Administration (NMPA) earlier this year for weight management in overweight and obesity, and will soon be submitted for type 2 diabetes as well after a second positive phase 3 trial,
Cesare Ferrari
JULY 22, 2024
One of the challenges in medical sales is disseminating the right messages to the right doctors at the right time. Previously, I discussed how to identify the right customer and pass the right message ; today’s post will focus on when to pass the message, knowing fully well that timing is critical. This is equally because the degree of difficulty of the “targeting at right time” challenge is unique to each specific message, campaign and customer.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PharmaTech
JULY 22, 2024
Accelerating a drug’s journey through early-phase development to commercialization can be made easy with precision equipment. Precision micro-dosing and powder-in-capsule (PIC) technology can help accelerate clinical trials supply and seamless scaling up from clinical to commercial manufacturing.
Penrod
JULY 22, 2024
Make sure your marketing team complies with the Ad Platform’s internal policies Apart from government regulations like HIPAA, the first barrier to risk are the guidelines of your ad platforms. Most digital ad platforms have internal policies specifically written for healthcare-based advertising. Restrictions are particularly stringent when it comes to pharmaceutical companies, but each platform has its own policies that must be adhered to.
Clarivate
JULY 22, 2024
A new report [1] from Clarivate patent experts provides an update on 5G standards-essential patent declarations. In our Demystifying the 5G standard essential patent landscape: Phase 4 report published in June 2023, we presented the statistics of patents declared as essential to 5G standards as of December 31, 2022. In this new report, we present statistics that capture new declarations, new 5G standards, new patent applications and new grants within the patent families.
PharmExec
JULY 22, 2024
In this part of his Pharmaceutical Executive video interview, Joshua M. Cohen, MD, MPH, FAHS, Chief Medical Officer, Braeburn discusses data from the Phase III trial recently published in JAMA and how confident they are in the generalizability of these findings to a real-world treatment setting.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
266 
Let's personalize your content